Associate Editor


Nikolaos Skartsis, MD, PhD

Clinical Instructor
Department of Medicine
University of California San Francisco
521 Parnassus Avenue, Box 0532
San Francisco, CA 94143, USA

Biography

I obtained my MD/ PhD from University of Patras Medical School-affiliate of John’s Hopkins Medical School. Pursued Post-Doc research fellowship in transplant immunology at Harvard Medical School. Completed Internal Medicine Residency at the Albert Einstein Medical Center before undertaking fellowship training in Nephrology at the University of California San Francisco.

Research Interest

Transplantation Costimulation blockade Regulatory T cells Renal Immunology Nephrology, Transplantation, Renal Immunology, Glomerulopathies, Neointimal Hyperplasia, Vascular Access failure

Scientific Activities

HONORS & AWARDS

2014 - Best Abstract Award: Hellenic Society of Nephrology - Alexandroupolis, Greece
2012 - Podium Award(2nd Winner): American Society of Diagnostic and Interventional Nephrology - New Orleans LA,USA
2012 - Best Abstract Award: Hellenic Society of Nephrology - Kyllini, Greece
2010 - National Excellence Grant Award(Ranked 5th in thenation): State Scholarship Foundation - Athens, Greece


CERTIFICATIONS & LICENCES

2015 - American Board of Internal Medicine Certification
2015 - California Medical Licence
2012 - Pennsylvania Medical Training License
2009 - ECFMG Certification
2009 - Micro Surgical Training Certificate: University of Miami Miller School of Medicine

Publications

Abstracts

1. Skartsis N, Batal I, Azzi J, Mounayar M, Ting C, Moore R, Abdi R Role of PI3kg pathway in the Activation of Innate Immune System by Oxidative Stress. Poster Presentation at American Transplant Congress 2012, Boston MA
2. Skartsis N, Azzi J, Tang L, Mounayar M, Ting C, Moore R, Cheng J, Abdi R Nanoparticle-mediated Targeted Delivery of Immunosuppression. Oral Presentation at American Transplant Congress 2012, Boston MA
3. Skartsis N, Liu W, Abdi R, Li XC Mechanisms of Natural Killer Cells in the Induction of Heart Allograft Tolerance. Poster Presentation at American Transplant Congress 2012, Boston MA
4. Azzi J, Skartsis N, Ting C, Moore R, Mounayar M, Abdi R Regulatory T cells Escape from Suicide by Increasing Cytoplasmic Serine Protease Inhibitor 6 (SPI6).Oral Presentation at American Transplant Congress 2012, Boston MA
5. Skartsis N, Pham SM, Tabbara M, Wei Y, Salman LH, Asif A, Vazquez-Padron RI RNA interference and inhibition of Stem Cell Factor (SCF)/c-kit signaling prevent neointimal hyperplasia in experimental fistulae. Oral presentation at American Society of Diagnostic and Interventional Nephrology 2012, New Orleans LA
6. Azzi JR, Moore R, Batal I, Akiyoshi T, Ting C, El Haddad N, Skartsis N, Sayegh M, Abdi R A Novel Role of PI3k gamma Inhibition in Suppressing Allo- and Autoimmunity in Islet Cell Trasplantation and Type 1 Diabetes. Poster presented at: American Transplant Congress 2011, Philadelphia PA
7. Azzi JR, Akiyoshi T, Batal I, Moore R, Ting C, El Haddad N, Skartsis N, Sayegh M, Abdi R The Emerging Role of Serine Protease Inhibitor 6 (SPI6) in Transplantation. Oral Presentation at: American Transplant Congress 2011, Philadelphia PA
8. Vazquez-Padron R, Skartsis N, Wei Y, Mateu D, Salman L, Asif A The role of Stem Cell Factor (SCF)/ c-kit signaling in vein stenosis Oral Presentation at: American Heart Association 2010, Chicago IL
9. Vazquez- Padron R, Manning E, Skartsis N, Mateu D, Wei Y, St-Pierre M, Salman L, Asif A The role of circulating versus local progenitor cells in vein stenosis Oral Presentation at: American Heart Association 2010, Chicago IL
10. Reddy CM, Levi DM, Skartsis N, Ghanta R, Martin P, Tzakis A, Island E, Selvaggi G, Tekin A, Nishida S, Moon J Recurrent HCC after Liver Transplantation in the MELD Era. Oral Presentation at: Digestive Disease Week 2010, New Orleans LA
11. Levi D, Maganty K, Skartsis N, Island E, Nishida S, Selvaggi G, Tekin A, Tzakis A Incidental HCC: Incidental but not incignificant. Poster presented at: American Transplant Congress 2009, Boston MA
12. Pararas N, DeFaria W, Levi D, Selvaggi G, Moon J, Nishida S, Tryphonopoulos P, Weppler D, Skartsis N, Sgouros N, Island E, Ruiz P, Tzakis A Mass clamping of the hilum to facilitate difficult native hepatectomy during liver transplantation. Poster presented at: American Transplant Congress 2009, Boston MA


Book Chapters, e- reference articles

Skartsis N, Brent L Complement (Lab essay). Medscape Reference, 2013


Peer reviewed Articles

(*asterisk indicates co-first authorship)


• Skartsis N*, Martinez L*, Duque JC*, Tabbara M, Velazquez O, Asif A, Andreopoulos F, Salman L, Vazquez-Padron R C-kit signaling determines neointimal hyperplasia in arteriovenous fistulae American Journal of Physiology- Renal Physiology 2014
• Azzi J*, Skartsis N*, Ting C, Moore R, Mounayar M, Batal I, Riella L, Magee C, Ashton-Richardt PG, Abdi R The emerging role of Serine Protease Inhibitor 6 in protecting Granzyme B producing regulatory T cells from suicide Journal of Immunology 2013
• Tang L, Azzi J, Kwon M, Mounayar M, Tong R, Yin Q, Moore R, Skartsis N, Fan TM, Abdi R, Cheng JJ Immunosuppressive activity of size-controlled PEG-PLGA nanoparticles containing encapsulated cyclosporine A Journal of Transplantation 2012
• Manning E, Skartsis N, Orta A, Velazquez OC, Liu ZJ, Salman L, Asif A, Vazquez- Padron RI A new arteriovenous fistula model to study the development of neointimal hyperplasia. Journal of Vascular Research 2012
• Skartsis N, Manning E, Wei Y, Velazquez OC, Liu ZJ, Goldschmidt- Clermont PJ, Salman LH, Asif A, Vazquez- Padron RI Origin of neointimal cells in arteriovenous fistulae: bone marrow, artery or the vein itself? Seminars in Dialysis 2011
• Levi DM, Tzakis A, Martin P, Nishida S, Island E, Moon J, Selvaggi G, Tekin A, Madrazo B, Narayanan G, Garcia M, Feun L, Tryphonopoulos P, Skartsis N, Livingstone A Liver Transplantation for Hepatocellular Carcinoma in the MELD Era. Journal of American College of Surgeons 2010